# Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept

> **NCT04809116** · PHASE4 · WITHDRAWN · sponsor: **Baylor College of Medicine**

## Conditions studied

- Insomnia Chronic
- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** Pimavanserin

## Key facts

- **NCT ID:** NCT04809116
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-12-15
- **Primary completion:** 2023-12-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Received alternative sources of funding.
- **Last updated:** 2023-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04809116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04809116, "Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04809116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*